Company Valuation: Kobayashi Pharmaceutical Co., Ltd.

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 704,427 650,295 503,841 463,131 403,511 410,870 - -
Change - -7.68% -22.52% -8.08% -12.87% 1.82% - -
Enterprise Value (EV) 1 596,011 546,554 424,992 398,232 333,575 344,867 340,642 334,769
Change - -8.3% -22.24% -6.3% -16.24% 3.39% -1.23% -1.72%
P/E 35.8x 34.8x 25.3x 46x 110x 39.2x 30x 24.4x
PBR 3.59x 3.47x 2.47x 2.18x 1.92x 1.94x 1.9x 1.84x
PEG - 12.08x 7.7x -0.9x -1.7x 0x 1x 1.1x
Capitalization / Revenue 4.54x 3.91x 2.9x 2.8x 2.43x 2.38x 2.28x 2.2x
EV / Revenue 3.84x 3.29x 2.45x 2.4x 2.01x 2x 1.89x 1.79x
EV / EBITDA 19.3x 17.1x 13.3x 12.1x 14.1x 15.3x 12.9x 11.1x
EV / EBIT 22.9x 20.5x 16.5x 16x 22.4x 25.7x 19.3x 15.5x
EV / FCF 31.8x 31.1x -350x -29.2x 68.5x 23.2x 22.4x 19.4x
FCF Yield 3.15% 3.22% -0.29% -3.42% 1.46% 4.3% 4.46% 5.14%
Dividend per Share 2 83 90 101 102 104 106 109.7 115
Rate of return 0.92% 1% 1.49% 1.64% 1.92% 1.92% 1.99% 2.08%
EPS 2 252.4 259.6 268.2 135.4 49.19 140.8 184.1 226.5
Distribution rate 32.9% 34.7% 37.7% 75.3% 211% 75.3% 59.6% 50.8%
Net sales 1 155,252 166,258 173,455 165,600 165,742 172,652 179,982 186,853
EBITDA 1 30,900 32,027 31,837 32,800 23,600 22,516 26,475 30,230
EBIT 1 26,065 26,669 25,780 24,860 14,923 13,440 17,657 21,601
Net income 1 19,715 20,022 20,338 10,067 3,656 10,453 13,621 16,694
Net Debt 1 -108,416 -103,741 -78,849 -64,899 -69,936 -66,004 -70,229 -76,101
Reference price 2 9,040.00 9,030.00 6,790.00 6,230.00 5,428.00 5,527.00 5,527.00 5,527.00
Nbr of stocks (in thousands) 77,923 72,015 74,203 74,339 74,339 74,339 - -
Announcement Date 2/4/22 2/14/23 2/9/24 2/10/25 2/10/26 - - -
1JPY in Million2JPY
Estimates

P/E, Detailed evolution

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
39.25x2x15.32x1.92% 2.53B
22.09x4.29x15.71x2.84% 349B
18.12x2.74x12.13x3.45% 135B
26.19x3.78x15.89x2.29% 74.4B
44.61x7.15x31.05x2.11% 52.31B
19.92x2.81x11.64x4.47% 36.44B
79.78x2.36x14.24x1.71% 29.71B
16.32x1.57x8.9x3.24% 19.89B
18.42x1.34x7.99x1.28% 19.85B
21.91x1.58x10.09x2.36% 18.43B
Average 30.66x 2.96x 14.30x 2.57% 73.82B
Weighted average by Cap. 25.39x 3.78x 15.37x 2.84%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield

  1. Stock Market
  2. Stocks
  3. 4967 Stock
  4. Valuation Kobayashi Pharmaceutical Co., Ltd.